The purpose of this research was to develop polylactic-co-glycolic acid (PLGA)
microspheres for continuous delivery of dexamethasone for over a 1-month period, in an …

The purpose of this research effort was to evaluate in vivo a newly developed
dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue …

Dexamethasone loaded PLGA microsphere/PVA hydrogel composites were investigated as
an outer drug-eluting coating for implantable devices to provide protection against the …

Background: Continuous release of dexamethasone from PLGA microsphere/PVA hydrogel
composites has been shown to suppress the inflammatory tissue reaction in response to …

Dexamethasone loaded poly (lactic-co-glycolic acid)(PLGA) microsphere/PVA hydrogel
composites have been investigated as an outer drug-eluting coating for implantable devices …

Background: Successful performance of implantable glucose biosensors for metabolic
monitoring is dependent on tissue compatibility. Negative immunostimulatory tissue …

The development of zero-order release systems capable of delivering drug (s) over
extended periods of time is deemed necessary for a variety of biomedical applications. We …

Dexamethasone (Dex)-loaded implants were prepared by poly (d, l-lactic acid)(PLA) and
poly (ethylene glycol)-block-poly (propylene glycol)-block-poly (ethylene glycol) copolymer …

Poly (lactic-co-glycolic acid)(PLGA) microsphere has been a useful tool in delivering
therapeutic drugs and biologically active proteins. In this study, a covered porous PLGA …

Polymer microspheres for controlled release of therapeutic protein from within an
implantable scaffold were produced and analysed using complimentary techniques to probe …